Stock Talk
Back to the basics - may be best to forget the meme stocks. Big money is on a short jihad of the stocks they named "the Dork" stocks. And the meme crowd can be like paper tigers, no - just make it like fickle cats. No group conviction like back in the original "days of meme".
Here's a few brief trading notes on some stocks we watch:
Lam Research (LRCX) - Chip foundries in America would be great for Lam Research. Etching and deposition, nobody does it better and right here in America. Yes, ASML guided cautiously but it's a foreign Dutch company and concerned about tariffs. Lam Research is based in America. Suggested here in the 60's and looking good to find a new range above $100. Holding some LRCX makes sense based on performance.
Kratos Defense & Security Solutions, Inc. (KTOS)
Europe wants in on KTOS with Airbus to develop a European variant of its KTOS XQ-58A Valkyrie drone. The collaboration aimed to deliver a combat-ready version of the uncrewed combat aircraft for the German Air Force by 2029. The Valkyrie is a low-observable drone designed for long-range missions.
Kinross Gold (KGC) - Watching KGC for coming market impact of higher gold and lower interest rates on the table by the September time frame. Who is to say that that KGC can't find the 20's as a next level if KGC can continue their trend of higher earnings and reducing debt at the same time? They did it last quarter- so ...?
METC and METCB- some whales and institutions are in as well as insiders holding. Perhaps they are thinking about a govt grant to spur the REE development at Brook Mine. Also, met coal price surged in China last week with jumps in futures as well.
Hewlett Packard Enterprise Company (HPE) - The need for AI servers has room for HPE with their adversity to use all kinds of chips like from AMD and Nvidia and others.
Rocket Labs (RKLB) has seen some selling pressure from institutions and whales raising some caution flags on near term share levels.
Oncolytics Biotech Inc. (ONCY) - After the Key Opinion Leader (KOL) event highlighting the mechanism of action on Pelareorep to combat various serious cancers, the market seemed to be asking - Ok well, is the new CEO waiting for partnerships and/or buyout deals to come to him OR is he proactively seeking deals with multiple big Pharma's? An open question here that remains to be seen how things may play out. Here, ONCY is now just a spec stock, only some stock or none. The market may be saying a partner is not so close to happening as we hoped. We don't have more than we can afford to lose in spec stocks.
If interested - scroll back and view notes on other stocks, we watch here at the Jones report. Why not? With the caveat that things change and we try to stay aware - It's all FREE to read and make your own calls and decisions. Finally - maintain some dry powder and trade or invest according to your own due diligence.
______________
More later so ....Stay tuned, if you dare !
For now, we close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time. But trying to look ahead a few months into the future may be a way to do things. If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. In all - we use the word maybe "some", not "too much" and play it accordingly. Remember, never get arrogant in our various notions because things do change in the market and individual stocks are subject to many factors outside of our control.. So we try to -stay aware.
With all the above caveats and attempted prognostications, I will close this post. Stay tuned for more opining on the market and stocks to watch.
___________
ALL in my humble opinion, scroll down and read more.This site does NOT make Buy / Sell recommendations.
________
